143 related articles for article (PubMed ID: 8309584)
1. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.
van Walderveen MA; Tas MW; Barkhof F; Polman CH; Frequin ST; Hommes OR; Valk J
Neurology; 1994 Feb; 44(2):327-9. PubMed ID: 8309584
[TBL] [Abstract][Full Text] [Related]
2. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
[TBL] [Abstract][Full Text] [Related]
3. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
[TBL] [Abstract][Full Text] [Related]
4. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
Thompson AJ; Miller D; Youl B; MacManus D; Moore S; Kingsley D; Kendall B; Feinstein A; McDonald WI
Neurology; 1992 Jan; 42(1):60-3. PubMed ID: 1734325
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy.
Larsson HB
Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161
[No Abstract] [Full Text] [Related]
6. Balo's concentric sclerosis. Report of two patients with magnetic resonance imaging follow-up.
Bolay H; Karabudak R; Tacal T; Onol B; Selekler K; Saribaş O
J Neuroimaging; 1996 Apr; 6(2):98-103. PubMed ID: 8634495
[TBL] [Abstract][Full Text] [Related]
7. Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
Barkhof F; Hommes OR; Scheltens P; Valk J
Neurology; 1991 Aug; 41(8):1219-22. PubMed ID: 1866009
[TBL] [Abstract][Full Text] [Related]
8. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
Rüttinger H; Hermes M
Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
[No Abstract] [Full Text] [Related]
9. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
11. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.
Kermode AG; Thompson AJ; Tofts P; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; Rudge P; McDonald WI
Brain; 1990 Oct; 113 ( Pt 5)():1477-89. PubMed ID: 2245307
[TBL] [Abstract][Full Text] [Related]
12. Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS.
Mattioli F; Cappa SF; Cominelli C; Capra R; Marcianoc N; Gasparotti R
Acta Neurol Scand; 1993 Jun; 87(6):465-8. PubMed ID: 8356876
[TBL] [Abstract][Full Text] [Related]
13. Database for serial magnetic resonance imaging in multiple sclerosis.
Barkhof F; Thompson AJ; Kappos L; Nauta JJ; Yousri T; Berry I; Scotti G; Appel B; Tofts PS; Miller DH
Neuroradiology; 1993; 35(5):362-6. PubMed ID: 8327113
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
Lai M; Hodgson T; Gawne-Cain M; Webb S; MacManus D; McDonald WI; Thompson AJ; Miller DH
J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):339-41. PubMed ID: 8609517
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in multiple sclerosis: an overview.
Colosimo M; Amatruda A; Cioffi RP
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
[TBL] [Abstract][Full Text] [Related]
16. The use of brain magnetic resonance imaging in multiple sclerosis.
Goodkin DE; Rudick RA; Ross JS
Arch Neurol; 1994 May; 51(5):505-16. PubMed ID: 8179501
[No Abstract] [Full Text] [Related]
17. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis.
Capra R; Marcianò N; Vignolo LA; Chiesa A; Gasparotti R
Arch Neurol; 1992 Jul; 49(7):687-9. PubMed ID: 1497493
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis.
Paavilainen T; Kurki T; Parkkola R; Färkkilä M; Salonen O; Dastidar P; Elovaara I; Airas L
Eur J Neurol; 2007 Nov; 14(11):1216-21. PubMed ID: 17727663
[TBL] [Abstract][Full Text] [Related]
19. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Miller DH; Rudge P; Johnson G; Kendall BE; Macmanus DG; Moseley IF; Barnes D; McDonald WI
Brain; 1988 Aug; 111 ( Pt 4)():927-39. PubMed ID: 3401689
[TBL] [Abstract][Full Text] [Related]
20. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
Paty DW; Li DK; Koopmans R
J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):978. PubMed ID: 1431970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
